NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Biotech Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Bioengineering



PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd.



October 8th, 2007

PAREXEL International Corporation (NASDAQ:PRXL), a leading global biopharmaceutical services organization, announced the successful completion of the acquisition of Taiwan-based APEX International Clinical Research Co., Ltd. ("APEX"). The acquisition strengthens PAREXEL's global capabilities, providing clients with a wide range of clinical research service offerings throughout the Asia- Pacific region, including mainland China, Hong Kong, India, Taiwan, Singapore, Indonesia, South Korea, Malaysia, Thailand, the Philippines, New Zealand, and Australia.

PAREXEL (Taiwan), Inc., a wholly owned subsidiary of PAREXEL, initiated a Tender Offer on June 29, 2007 to purchase all...


Source: Biotech Business Week (2007-10-08)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login